Evaluation of the brain 5-HT2A receptor binding index in dogs with anxiety disorders, measured with 123I-5I-R91150 and SPECT

Journal of Nuclear Medicine

Volumn 50, Issue 2, 2009, Pages 284-289

  Vermeire, Simon T ^a   Audenaert, Kurt R ^a   Dobbeleir, André A ^a   De Meester, Rudy H ^a   De Vos, Filip J ^a   Peremans, Kathelijne Y ^a  

^a GHENT UNIVERSITY   (Belgium)

Author keywords

5 HT2A receptor; Anxiety disorders; Dog; Serotonin (5 HT); SPECT

Indexed keywords

SEROTONIN 2A RECEPTOR; TRACER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY; ANXIETY DISORDER; ARTICLE; BRAIN CORTEX; BRAIN REGION; CONTROLLED STUDY; DOG; DRUG RECEPTOR BINDING; FEMALE; MALE; NONHUMAN; OCCIPITAL CORTEX; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ANIMALS; ANXIETY; BRAIN; DOG DISEASES; DOGS; FEMALE; IODINE RADIOISOTOPES; MALE; PIPERIDINES; RADIOPHARMACEUTICALS; RECEPTOR, SEROTONIN, 5-HT2A; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 59249095067     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.108.055731     Document Type: Article

References (40)

1. Hensler JG. Serotonergic modulation of the limbic system. Neurosci Biobehav Rev. 2006;30:203-214.
2. Murphy DL, Pigott TA. A comparative examination of a role for serotonin in obsessive compulsive disorder, panic disorder, and anxiety. J Clin Psychiatry. 1990;51(suppl):S53-S58.
3. Fernandez M, Pissiota A, Frans O, von Knorring L, Fischer H, Fredrikson M. Brain function in a patient with torture related post-traumatic stress disorder before and after fluoxetine treatment: a positron emission tomography provocation study. Neurosci Lett. 2001;297:101-104.
4. Stein DJ, Ipser JC, Balkom AJ. Pharmacotherapy for social anxiety disorder. Cochrane Database Syst Rev. 2000;CD001206.
5. Westenberg HG, Liebowitz MR. Overview of panic and social anxiety disorders. J Clin Psychiatry. 2004;65(suppl 14):S22-S26.
6. Gorman JM, Kent JM, Sullivan GM, Coplan JD. Neuroanatomical hypothesis of panic disorder, revised. Am J Psychiatry. 2000;157:493-505.
7. Blier P. Norepinephrine and selective norepinephrine reuptake inhibitors in depression and mood disorders: their pivotal roles. J Psychiatry Neurosci. 2001;26(suppl):S1-S2.
8. Szabo ST, Blier P. Functional and pharmacological characterization of the modulatory role of serotonin on the firing activity of locus coeruleus norepinephrine neurons. Brain Res. 2001;922:9-20.
9. Inada Y, Yoneda H, Koh J, et al. Positive association between panic disorder and polymorphism of the serotonin 2A receptor gene. Psychiatry Res. 2003;118:25-31.
10. Unschuld PG, Ising M, Erhardt A, et al. Polymorphisms in the serotonin receptor gene HTR2A are associated with quantitative traits in panic disorder. Am J Med Genet B Neuropsychiatr Genet. 2007;144B:424-429.
11. Bremner JD. Brain imaging in anxiety disorders. Expert Rev Neurother. 2004;4:275-284.
12. Audenaert K, Van LK, Dumont F, et al. Decreased 5-HT2a receptor binding in patients with anorexia nervosa. J Nucl Med. 2003;44:163-169.
13. van Heeringen C, Audenaert K, Van Laere K, et al. Prefrontal 5-HT2a receptor binding index, hopelessness and personality characteristics in attempted suicide. J Affect Disord. 2003;74:149-158.
14. 123I-5-I-R91150 in the normal dog. Nucl Med Commun. 2002;23:1019-1027.
15. 123I-5-I-R91150. Eur J Nucl Med Mol Imaging. 2003;30:1538-1546.
16. 123I-5-I-R91150 SPECT. Eur J Nucl Med Mol Imaging. 2005;32:708-716.
17. Starkey MP, Scase TJ, Mellersh CS, Murphy S. Dogs really are man's best friend: canine genomics has applications in veterinary and human medicine! Brief Funct Genomics Proteomics. 2005;4:112-128.
18. Hsu YY, Serpell JA. Development and validation of a questionnaire for measuring behavior and temperament traits in pet dogs. J Am Vet Med Assoc. 2003;223:1293-1300.
19. Case LP. The Dog: Its Behavior, Nutrition, and Health. 2nd ed. Ames, IA: Blackwell Publishing; 2005:215-226.
20. Peremans K, De Bondt P, Audenaert K, et al. Regional brain perfusion in 10 normal dogs measured using technetium-99m ethyl cysteinate dimer spect. Vet Radiol Ultrasound. 2001;42:562-568.
21. 2-receptors: a promising tracer for gamma-emission tomography. J Labelled Comp Radiopharm. 1994;34:795-806.
22. Pazos A, Probst A, Palacios JM. Serotonin receptors in the human brain: IV. Autoradiographic mapping of serotonin-2 receptors. Neuroscience. 1987;21:123-139.
23. Peremans K, Audenaert K, Blanckaert P, et al. Effects of aging on brain perfusion and serotonin-2A receptor binding in the normal canine brain measured with single photon emission tomography. Prog Neuropsychopharmacol Biol Psychiatry. 2002;26:1393-1404.
24. Nic Dhonnchadha BA, Hascoet M, Jolliet P, Bourin M. Evidence for a 5-HT2A receptor mode of action in the anxiolytic-like properties of DOI in mice. Behav Brain Res. 2003;147:175-184.
25. Biver F, Wikler D, Lotstra F, Damhaut P, Goldman S, Mendlewicz J. Serotonin 5-HT2 receptor imaging in major depression: focal changes in orbito-insular cortex. Br J Psychiatry. 1997;171:444-448.
26. Yatham LN, Liddle PF, Shiah IS, et al. Brain serotonin2 receptors in major depression: a positron emission tomography study. Arch Gen Psychiatry. 2000;57:850-858.
27. Zanardi R, Artigas F, Moresco R, et al. Increased 5-hydroxytryptamine-2 receptor binding in the frontal cortex of depressed patients responding to paroxetine treatment: a positron emission tomography scan study. J Clin Psychopharmacol. 2001;21:53-58.
28. Audenaert K, Van LK, Dumont F, et al. Decreased frontal serotonin 5-HT 2a receptor binding index in deliberate self-harm patients. Eur J Nucl Med. 2001;28:175-182.
29. Weisstaub NV, Zhou M, Lira A, et al. Cortical 5-HT2A receptor signaling modulates anxiety-like behaviors in mice. Science. 2006;313:536-540.
30. Esler M, Lambert E, Alvarenga M, et al. Increased brain serotonin turnover in panic disorder patients in the absence of a panic attack: reduction by a selective serotonin reuptake inhibitor. Stress. 2007;10:295-304.
31. Hashimoto S, Inoue T, Koyama T. Effects of conditioned fear stress on serotonin neurotransmission and freezing behavior in rats. Eur J Pharmacol. 1999;378:23-30.
32. Watson JM, Dawson LA. Characterization of the potent 5-HT(1A/B) receptor antagonist and serotonin reuptake inhibitor SB-649915: preclinical evidence for hastened onset of antidepressant/anxiolytic efficacy. CNS Drug Rev. 2007;13:206-223.
33. Lochner C, Hemmings S, Seedat S, et al. Genetics and personality traits in patients with social anxiety disorder: a case-control study in South Africa. Eur Neuropsychopharmacol. 2007;17:321-327.
34. Ressler KJ, Nemeroff CB. Role of serotonergic and noradrenergic systems in the pathophysiology of depression and anxiety disorders. Depress Anxiety. 2000;12(suppl 1):S2-S19.
35. LeDoux JE. Emotion circuits in the brain. Annu Rev Neurosci. 2000;23:155-184.
36. Kent JM, Rauch SL. Neurocircuitry of anxiety disorders. Curr Psychiatry Rep. 2003;5:266-273.
37. Morgan MA, Romanski LM, LeDoux JE. Extinction of emotional learning: contribution of medial prefrontal cortex. Neurosci Lett. 1993;163:109-113.
38. Lucey JV, Costa DC, Busatto G, et al. Caudate regional cerebral blood flow in obsessive-compulsive disorder, panic disorder and healthy controls on single photon emission computerised tomography. Psychiatry Res. 1997;74:25-33.
39. Mukaida K, Shichino T, Koyanagi S, Himukashi S, Fukuda K. Activity of the serotonergic system during isoflurane anesthesia. Anesth Analg. 2007;104:836-839.
40. Zhang Y, Laster MJ, Eger EI, Stabernack CR, Sonner JM. Blockade of 5-HT2A receptors may mediate or modulate part of the immobility produced by inhaled anesthetics. Anesth Analg. 2003;97:475-479.